![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens
|
|
|
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
A Luetkemeyer,1 C Mcdonald,2 M Ramgopal,3 S Noviello,4 R Bhore,5 P Ackerman61University of California, San Francisco, CA, USA; 2Tarrant County Infection Disease Associates, Fort Worth, TX, USA; 3Midway Immunology and Research Center, Fort Pierce, FL, USA; 4Bristol-Myers Squibb, Lawrenceville, NJ, USA; 5Bristol-Myers Squibb, Hopewell, NJ, USA; 6Bristol-Myers Squibb, Wallingford, CT, USA.
![IDSA1.gif](../images/101415/101415-3/IDSA1.gif)
![IDSA2.gif](../images/101415/101415-3/IDSA2.gif)
![IDSA3.gif](../images/101415/101415-3/IDSA3.gif)
![IDSA4.gif](../images/101415/101415-3/IDSA4.gif)
![IDSA5.gif](../images/101415/101415-3/IDSA5.gif)
![IDSA6.gif](../images/101415/101415-3/IDSA6.gif)
![IDSA7.gif](../images/101415/101415-3/IDSA7.gif)
![IDSA8.gif](../images/101415/101415-3/IDSA8.gif)
![IDSA9.gif](../images/101415/101415-3/IDSA9.gif)
![IDSA10.gif](../images/101415/101415-3/IDSA10.gif)
![IDSA11.gif](../images/101415/101415-3/IDSA11.gif)
![IDSA12.gif](../images/101415/101415-3/IDSA12.gif)
![IDSA13.gif](../images/101415/101415-3/IDSA13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|